ReviewJournal of diabetes and metabolic disorders2026
Pooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis.
Review in Journal of diabetes and metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Anxiety and depressive symptoms are highly prevalent among individuals with type 2 diabetes mellitus (T2DM), yet they remain underdiagnosed despite their substantial impact on health outcomes. In addition to impairing treatment adherence, these conditions may contribute to the development of chronic complications, reduce quality of life, and, in severe cases, increase mortality. Therefore, this review aims to estimate the pooled prevalence of anxiety symptoms and depressive symptoms among adults with T2DM and to explore potential sources of between-study heterogeneity, including assessment instruments and cut-off points. Methods: PubMed, Embase, PsycINFO, Scopus, and Web of Science were searched from inception to July 6, 2026. After screening 6,948 records according to PRISMA 2020, 34 cross-sectional studies involving 21,024 participants were included. We considered observational studies involving adults with T2DM that reported the prevalence of anxiety symptoms or depressive symptoms assessed using validated screening instruments or diagnostic criteria. Two reviewers independently screened the records, extracted the data, and assessed the risk of bias. Separate random-effects meta-analyses were conducted for anxiety symptoms and depressive symptoms. Results: Thirty-four cross-sectional studies involving 21,024 participants were included. The pooled prevalence was 43.82% for anxiety symptoms (95% CI 36.86-50.90; [Formula: see text]) and 41.83% for depressive symptoms (95% CI 33.83-50.06; [Formula: see text]). Estimates varied substantially across assessment instruments and cut-off points. Several studies reported associations with sex, glycemic control, and social support; however, differences in the definitions, measurements, and analytical methods prevented quantitative pooling of these factors. Conclusion: Anxiety and depressive symptoms were frequently reported among adults with T2DM. However, the extreme between-study heterogeneity limits the interpretation of the pooled estimates, which should be understood as summary measures across diverse study populations rather than universal prevalence estimates. These findings should not be interpreted as estimates of clinically diagnosed anxiety or depressive disorders. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s40200-026-02079-z.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.